Oshima, H.; Takamura, Y.; Hirano, T.; Shimura, M.; Sugimoto, M.; Kida, T.; Matsumura, T.; Gozawa, M.; Yamada, Y.; Morioka, M.;
et al. Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema. J. Clin. Med. 2022, 11, 4659.
https://doi.org/10.3390/jcm11164659
AMA Style
Oshima H, Takamura Y, Hirano T, Shimura M, Sugimoto M, Kida T, Matsumura T, Gozawa M, Yamada Y, Morioka M,
et al. Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema. Journal of Clinical Medicine. 2022; 11(16):4659.
https://doi.org/10.3390/jcm11164659
Chicago/Turabian Style
Oshima, Hideyuki, Yoshihiro Takamura, Takao Hirano, Masahiko Shimura, Masahiko Sugimoto, Teruyo Kida, Takehiro Matsumura, Makoto Gozawa, Yutaka Yamada, Masakazu Morioka,
and et al. 2022. "Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema" Journal of Clinical Medicine 11, no. 16: 4659.
https://doi.org/10.3390/jcm11164659
APA Style
Oshima, H., Takamura, Y., Hirano, T., Shimura, M., Sugimoto, M., Kida, T., Matsumura, T., Gozawa, M., Yamada, Y., Morioka, M., & Inatani, M.
(2022). Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema. Journal of Clinical Medicine, 11(16), 4659.
https://doi.org/10.3390/jcm11164659